Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD109 is a potential target for triple-negative breast cancer.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Dec 2014

Tao Ji, Li Hongbin, Li Qingwei, Yang Yu

Abstract excerpt

The aim of this study is to explore the expression of CD109 in breast cancer stem cells and the relationship between CD109 protein and clinicopathological characteristics of breast cancer. CD44+/CD24- tumor cells (CSCs) were selected by flow cytometry. The protein expression of CD109 was analyzed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Spheroids, Cellular
Share to Neoplasm Metastasis
Share to GPI-Linked Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Molecular Targeted Therapy

Share to Neoadjuvant Therapy

Share to Neoplasm Grading

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 25149155
DOI: 10.1007/s13277-014-2509-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25149155-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

CD109 is a potential target for triple-negative breast cancer.PMID 25149155Read ↗

CD109 and squamous cell carcinomaSemantic proximity Read ↗

CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling AxisSemantic proximity Read ↗

Expression of CD109 in human cancerSemantic proximity Read ↗

CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cellsSemantic proximity Read ↗

NEDD4 Plays Roles in the Maintenance of Breast Cancer Stem Cell CharacteristicsSemantic proximity Read ↗

CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitroSemantic proximity Read ↗

SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC.Semantic proximity Read ↗

CD109 drives pro-tumorigenic cell properties in human non-small cell lung cancer through interaction with desmoglein-2Semantic proximity Read ↗

Transmembrane protein TMEM119 facilitates the stemness of breast cancer cells by activating Wnt/β-catenin pathwaySemantic proximity Read ↗

Cordycepin Inhibits Growth and Metastasis Formation of MDA-MB-231 Xenografts in Nude Mice by Modulating the Hedgehog PathwaySemantic proximity Read ↗

Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.